share_log

Lifeist Wellness Reports Continuing Improved Trends in Q3 2021

Lifeist Wellness Reports Continuing Improved Trends in Q3 2021

Lifeist Wellness 报告称 2021 年第三季度趋势持续改善
GlobeNewswire ·  2021/10/29 19:30

Quarterly Financial Metrics

季度财务指标

Depicts quarterly financial metrics
描述季度财务指标

-- Improvement in Key Metrics: Revenue Growth, Adj. Gross Profit, Operating Cashflow
-- Execution in Cannabis as Company Pursues Emerging Nutraceuticals Opportunity

--关键指标的改善:收入增长、调整后的毛利、运营现金流
--公司追求新兴营养品机遇之际在大麻领域的执行

TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a wellness company that leverages advancements in science and technology to enable you to find your path to wellness, today reported its financial results for the three and nine months ended August 31, 2021. All financial figures are in Canadian dollars unless otherwise indicated.

多伦多,2021 年 10 月 29 日(GLOBE NEWSWIRE)— Lifeist健康公司“生活主义者” 或 “公司”“) (TSXV: LFST)(法兰克福:M5B)(OTCMKTS:NXTTF), 一家利用科学和技术进步使您能够找到健康之路的健康公司,今天公布了截至2021年8月31日的三个月和九个月的财务业绩。除非另有说明,否则所有财务数字均以加元为单位。

Third Quarter 2021 Financial Highlights

2021 年第三季度财务摘要

  • Gross revenue increased 12% year-over-year to $7.1 million, led by cannabis growth of 34%.
  • Gross profit and margin more than doubled year-over-year to $0.9 million and 15% of Net revenue (23% before inventory adjustment), the fourth consecutive quarterly improvement.
  • EBITDA loss narrowed to $5.4 million compared to $7.3 million in Q3 2020 and $5.9 million in Q2 2021, even with incremental investments into emerging businesses including nutraceuticals.
  • Net cash used in operating activities decreased from $5.7 million in Q2 2021 to $4.9 million in Q3 2021.
  • Inventory management continues to improve with reduced turnover days and lower holdings of inventory.
  • Working capital position of $19.5 million at quarter end remains strong.
  • 在大麻增长34%的带动下,总收入同比增长12%,达到710万美元。
  • 毛利和利润率同比翻了一番多,达到90万美元,占净收入的15%(库存调整前为23%),这是连续第四个季度增长。
  • 息税折旧摊销前利润亏损从2020年第三季度的730万美元和2021年第二季度的590万美元缩小至540万美元,尽管对包括营养保健品在内的新兴业务的投资有所增加。
  • 用于经营活动的净现金从2021年第二季度的570万美元下降到2021年第三季度的490万美元。
  • 随着周转天数的减少和库存的减少,库存管理继续得到改善。
  • 截至季度末,营运资金状况为1,950万美元,依然强劲。

"Our improved third quarter results reflect ongoing positive trends: higher revenue, lower costs, and better cash flow," said Meni Morim, CEO of Lifeist. "We are seeing the early payoff from our focus on where we can deliver more profitable growth, operate more efficiently, and optimize working capital within our current portfolio of businesses while we invest in the future. We are pressing forward with our plans to develop nutraceuticals products with a new business unit launching this quarter, enabling Lifeist to transition to sustainable profitability. The improved performance in our cannabis business while we invest in this emerging opportunity reinforces our confidence in our strategy and we expect continued top-line growth and improvements in profitability as we navigate through this transformation. Overall, there has been a significant amount of work done across the Company laying the foundations for growth as we continue our company's evolution to wellness."

Lifeist首席执行官梅尼·莫里姆表示:“我们第三季度业绩的改善反映了持续的积极趋势:收入增加、成本降低和现金流改善。”“在投资未来的同时,我们专注于在当前业务组合中实现更有利可图的增长、更高效的运营和优化营运资金,这使我们看到了早期的回报。我们正在推进开发营养保健品产品的计划,本季度将成立一个新的业务部门,使Lifeist能够过渡到可持续的盈利能力。在我们投资这一新兴机会的同时,大麻业务的业绩有所改善,这增强了我们对战略的信心,我们预计,随着这种转型,收入将持续增长,盈利能力将得到改善。总体而言,在我们继续向健康发展的过程中,整个公司已经做了大量工作,为增长奠定了基础。”

Added Mr. Morim, "In particular, the financial turnaround is being led by our cannabis subsidiary, CannMart, Inc., which is experiencing strong demand for its portfolio of products from consumers, retailers and provincial wholesalers across Canada as evidenced by the 34% growth in cannabis revenue in the quarter. What makes CannMart unique is its ability to bring brands to market quickly, whether it be via the increasing number of master distribution agreements that we are signing where we act as the middleman, or via the expansion of our product portfolio with the launch of our limited-edition SKUs made at our subsidiary CannMart Labs's state-of-the-art BHO extraction facility."

莫里姆先生补充说:“特别是,财务转机是由我们的大麻子公司CannMart, Inc. 带动的,加拿大各地的消费者、零售商和省级批发商对其产品组合的需求强劲,本季度大麻收入增长34%就是明证。CannMart的独特之处在于它能够将品牌快速推向市场,无论是通过我们作为中间人签署的越来越多的主分销协议,还是通过在子公司CannMart Labs最先进的BHO提取设施推出限量版SKU来扩大我们的产品组合。”

Operational Highlights

运营亮点

  • CannMart Inc. continues to enter into partnerships with third parties to be their wholesale and logistics partner in order to take advantage of the trend where Canadian licensed producers (LPs) and manufacturers are looking to outsource parts of their operations that are not core. During the third quarter, CannMart Inc. signed Master Distribution Agreements with several companies including with Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) to exclusively distribute RDT's innovative RDT branded products across Canada.
  • CannMart Inc. received its first purchase orders from the provinces of Manitoba, and Saskatchewan for its 2.0 consumer-focused recreational house brand "Roilty" concentrates.
  • As part of its focus on the broader wellness space, the Company changed its corporate name from Namaste Technologies Inc. to Lifeist Wellness Inc. effective September 9, 2021, and changed its stock ticker symbol on the TSXV to its current symbol "LFST".
  • Lifeist continues to look for ways to operate more efficiently, including subleasing its former Toronto office headquarters which is expected to generate annual run rate savings of approximately $138,000 until expiry of its lease in October 2024, as well as consolidating headcount, software and marketing costs across divisions in order to reduce costs and reallocate resources more efficiently across the Company, and implementing inventory control measures on the cannabis business to reduce carrying costs.
  • CannMart Inc. 继续与第三方建立合作伙伴关系,成为他们的批发和物流合作伙伴,以利用加拿大特许生产商(LP)和制造商寻求将部分非核心业务外包的趋势。在第三季度,CannMart Inc.与包括Rapid Dose Therapeutics Corp.(“RDT”)(CSE:DOSE)在内的多家公司签署了主分销协议,在加拿大各地独家分销RDT的创新RDT品牌产品。
  • CannMart Inc. 收到了来自曼尼托巴省和萨斯喀彻温省的第一份采购订单,用于其以2.0消费者为中心的休闲住宅品牌 “Roilty” 浓缩物。
  • 作为专注于更广泛的健康领域的一部分,该公司自2021年9月9日起将其公司名称从Namaste Technologies Inc.更名为Lifeist Wellness Inc.,并将多伦多证券交易所的股票代码改为目前的代码 “LFST”。
  • Lifeist继续寻找提高运营效率的方法,包括转租其前多伦多办事处总部,预计在2024年10月租约到期之前,每年将节省约13.8万美元的运营成本,以及整合各部门的员工人数、软件和营销成本,以降低成本和更有效地在公司内部重新分配资源,以及对大麻业务实施库存控制措施以降低运营成本。

Financial Summary of Q3 2021 and Comparative Periods

2021年第三季度及比较期财务摘要

  Q3 2020 Q2 2021 Q3 2021   YTD 2020 YTD 2021
Gross revenue $ 6,281,875   $ 6,266,808   $ 7,067,091     $ 19,099,640   $ 19,482,586  
Net revenue $ 5,684,847   $ 5,275,779   $ 5,787,750     $ 17,918,313   $ 16,578,264  
Gross profit (before inventory adjustment) $ 552,381   $ 753,613   $ 1,305,806     $ 1,915,159   $ 2,513,468  
Gross profit % (before inventory adjustment)   10 %   14 %   23 %     11 %   15 %
Net loss $ (7,833,495 ) $ (6,369,642 ) $ (6,053,422 )   $ (20,067,533 ) $ (19,804,507 )
Net loss per share (basic and diluted) $ (0.02 ) $ (0.02 ) $ (0.02 )   $ (0.06 ) $ (0.06 )
Total assets $ 46,481,236   $ 46,328,594   $ 41,221,145     $ 46,481,236   $ 41,221,145  
Cash used in operating activities $ (5,262,843 ) $ (5,674,692 ) $ (4,909,845 )   $ (20,506,989 ) $ (13,051,970 )
  2020 年第三季度 2021 年第二季度 2021 年第三季度   2020年年初至今 2021 年年初
总收入 $ 6,281,875   $ 6,266,808   $ 7,067,091     $ 19,099,640   $ 19,482,586  
净收入 $ 5,684,847   $ 5,275,779   $ 5,787,750     $ 17,918,313   $ 16,578,264  
毛利(库存调整前) $ 552,381   $ 753,613   $ 1,305,806     $ 1,915,159   $ 2,513,468  
毛利百分比(库存调整前)   10 %   14 %   23 %     11 %   15 %
净亏损 $ (7,833,495 ) $ (6,369,642 ) $ (6,053,422) )   $ (20,067,533 ) $ (19,804,507) )
每股净亏损(基本亏损和摊薄后) $ (0.02) ) $ (0.02) ) $ (0.02 )   $ (0.06 ) $ (0.06 )
总资产 $ 46,481,236   $ 46,328,594   $ 41,221,145     $ 46,481,236   $ 41,221,145  
用于经营活动的现金 $ (5,262,843 ) $ (5,674,692 ) $ (4,909,845 )   $ (20,506,989 ) $ (13,051,970 )

Gross revenue increased 12% to $7.1 million in Q3 2021, as compared to $6.3 million in Q3 2020. This growth was driven by the Company's cannabis business which increased 34% due to increased volume of orders from provincial customers, enhanced product selection and a new dropship revenue stream added in Q3 2021. In addition, SaaS revenue increased 9% as compared to Q3 2020.

2021年第三季度的总收入增长了12%,达到710万美元,而2020年第三季度为630万美元。这一增长是由该公司的大麻业务推动的,该业务增长了34%,这要归因于省级客户的订单量增加,产品选择的增加以及2021年第三季度增加了新的直销收入来源。此外,与2020年第三季度相比,SaaS的收入增长了9%。

Adjusted gross margin, before inventory write-down, was 23% of Net revenue in Q3 2021 compared to 10% in Q3 2020 and 14% in Q2 2021. The 1,300-basis point improvement year-over-year was due to improved production efficiencies across all segments.

存货减记前的调整后毛利率为2021年第三季度净收入的23%,而2020年第三季度为10%,2021年第二季度为14%。同比增长1300个基点是由于所有细分市场的生产效率提高。

EBITDA loss narrowed to $5.4 million in Q3 2021 compared to $7.3 million in Q3 2020, due to improved performance across most business units. The reduced EBITDA loss was net of approximately $1 million of investments in emerging businesses including CannMart Labs and nutraceuticals.

由于大多数业务部门的业绩有所改善,2021年第三季度的息税折旧摊销前利润亏损从2020年第三季度的730万美元缩小至540万美元。减少的息税折旧摊销前利润亏损中扣除了对包括CannMart Labs和Nutraceuticals在内的新兴业务的约100万美元投资。

Net loss in Q3 2021 was $6.1 million, largely impacted by increased Salaries and Selling and Marketing costs, as a result of a strategic investment in the growth of core business segments as well as an upfront investment in the nutraceutical segment.

2021年第三季度的净亏损为610万美元,这主要是由于对核心业务板块增长的战略投资以及对营养保健品领域的前期投资,工资以及销售和营销成本的增加。

Balance Sheet and Cash Flow

资产负债表和现金流

Cash and cash equivalents were $17.9 million as of August 31, 2021, compared to $23.0 million as of May 31, 2021, which is sufficient to fund planned growth initiatives.

截至2021年8月31日,现金及现金等价物为1,790万美元,而截至2021年5月31日为2,300万美元,足以为计划中的增长计划提供资金。

Demonstrating continued improved inventory management practices, inventories decreased to $4.9 million compared to $5.2 million in Q2 2021 and $6.0 million in Q1 2021.

库存从2021年第二季度的520万美元和2021年第一季度的600万美元降至490万美元,这表明库存管理实践持续改善。

Net cash used in operations was $4.9 million for the quarter. This is the third consecutive quarter in which the Company demonstrated EBITDA loss improvements.

本季度用于运营的净现金为490万美元。这是该公司连续第三个季度显示息税折旧摊销前利润亏损有所改善。

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6542334e-7ea0-427f-8ea9-a73412adcc5d

本公告附带的照片可在以下网址获得 https://www.globenewswire.com/NewsRoom/AttachmentNg/6542334e-7ea0-427f-8ea9-a73412adcc5d

Additional Information

附加信息

Financial results and analysis are available on Lifeist's website (www.lifeist.com) and SEDAR (www.sedar.com).

财务业绩和分析可在Lifeist的网站(www.lifeist.com)和SEDAR(www.sedar.com)上查阅。

About Lifeist Wellness Inc.

关于 Lifeist Wellness

Lifeist is at the forefront of the post-pandemic wellness revolution requiring smart solutions. Lifeist is a portfolio wellness company leveraging advancements in science and technology to enable you to find your path to wellness. Portfolio business units include: CannMart.com that provides Canadian medical customers with a diverse selection of cannabis products from a multitude of federally licensed cultivators and its U.S. customers with access to hemp-derived CBD and smoking accessories; and CannMart's Canadian recreational cannabis distribution business facilitating recreational sales to a number of provincial government control boards. The Company is set to launch a new nutraceuticals division in the fourth quarter with disruptive products in wellness. For more information, visit www.lifeist.com, Cannmart.com and everyonedoesit.co.uk.

Lifeist 处于疫情后健康革命的最前沿,需要智能解决方案。Lifeist是一家投资组合健康公司,利用科学和技术的进步,使您能够找到通往健康的道路。投资组合业务部门包括:CannMart.com为加拿大医疗客户提供来自众多联邦许可种植者的各种大麻产品,其美国客户可以获得大麻衍生的CBD和吸烟配件;以及CannMart的加拿大休闲大麻分销业务,促进向多个省政府控制委员会进行娱乐性销售。该公司将在第四季度成立一个新的营养品部门,在健康领域提供颠覆性的产品。欲了解更多信息,请访问 www.lifeist.com、Cannmart.com 和 everyonedoesit.co.uk。

Contacts

联系人

Lifeist Wellness Inc.
Meni Morim, CEO
Matt Chesler, CFA, Investor Relations
Ph: 647-362-0390
Email: ir@lifeist.com

Lifeist健康公司
梅尼·莫里姆,首席执行官
Matt Chesler,首席财务官,投资者关系
Ph: 647-362-0390
电子邮件:ir@lifeist.com

Non-IFRS Financial Measures

非国际财务报告准则财务指标

Management evaluates the Company's performance using a variety of measures, including "Net loss before income tax, depreciation and amortization" and "Adjusted EBITDA". The non-IFRS measures discussed below should not be considered as an alternative to or to be more meaningful than revenue or net loss. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

管理层使用各种衡量标准来评估公司的业绩,包括 “所得税、折旧和摊销前的净亏损” 和 “调整后的息税折旧摊销前利润”。下文讨论的非国际财务报告准则指标不应被视为收入或净亏损的替代方案,也不应被视为比收入或净亏损更有意义。这些指标不具有《国际财务报告准则》规定的标准化含义,因此它们可能无法与其他上市公司提出的类似标题的指标相提并论,不应被解释为根据《国际财务报告准则》确定的其他财务指标的替代方案。

The Company believes these non-IFRS financial measures provide useful information to both management and investors in measuring the financial performance and financial condition of the Company.

公司认为,这些非国际财务报告准则财务指标为管理层和投资者提供了衡量公司财务业绩和财务状况的有用信息。

Management uses these and other non-IFRS financial measures to exclude the impact of certain expenses and income that must be recognized under IFRS when analyzing consolidated underlying operating performance, as the excluded items are not necessarily reflective of the Company's underlying operating performance and make comparisons of underlying financial performance between periods difficult. From time to time, the Company may exclude additional items if it believes doing so would result in a more effective analysis of underlying operating performance. The exclusion of certain items does not imply that they are non-recurring.

管理层在分析合并基础经营业绩时,使用这些指标和其他非国际财务报告准则财务指标来排除根据国际财务报告准则必须确认的某些支出和收入的影响,因为排除的项目不一定反映公司的基础经营业绩,因此很难比较不同时期之间的基础财务业绩。如果公司认为这样做可以更有效地分析基础经营业绩,则可能会不时排除其他项目。排除某些项目并不意味着它们是非经常性的。

(i) Current and deferred income taxes, depreciation and amortization, and share-based compensation were excluded from the Adjusted EBITDA calculation as they do not represent cash expenditures.
(ii) Other income consisting of gain on disposal of subsidiary, interest income, realized gain on disposition of AFS investments, unrealized gain on derivatives and other miscellaneous non-recurring income were excluded from Adjusted EBITDA calculation.
(iii) Non-recurring costs related to restructuring and legacy issues were excluded from Adjusted EBITDA calculation.
(iv) Impairment loss relating to goodwill, customer list, domains and brand names were excluded from Adjusted EBITDA calculation.
(v) Impairment loss relating to receivable is a provision for expected credit loss to an associate and was excluded from Adjusted EBITDA calculation.
(vi) Share of associates loss, net of tax, is excluded due to lack of control.

(i) 调整后息税折旧摊销前利润的计算中不包括当期和递延所得税、折旧和摊销以及基于股份的薪酬,因为它们不代表现金支出。
(ii) 调整后息税折旧摊销前利润的计算中不包括其他收入,包括出售子公司的收益、利息收入、处置AFS投资的已实现收益、衍生品未实现收益和其他杂项非经常性收入。
(iii) 调整后息税折旧摊销前利润的计算中不包括与重组和遗留问题相关的非经常性成本。
(iv) 调整后息税折旧摊销前利润的计算中不包括与商誉、客户名单、域名和品牌名称相关的减值损失。
(v) 与应收账款相关的减值损失是联营公司的预期信用损失准备金,不包括在调整后的息税折旧摊销前利润的计算中。
(vi) 由于缺乏控制,扣除税款后的关联亏损份额不包括在内。

Forward-Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新闻稿包含适用证券法所指的 “前瞻性信息”。此处包含的所有非历史性陈述均包含前瞻性信息。前瞻性信息可以通过单词或短语来识别,例如 “可能”、“期望”、“可能”、“应该”、“将”、“计划”、“预期”、“打算”、“潜在”、“提议”、“估计”、“相信” 或这些术语的否定词、表达方式和语法变体,或某些事件或条件 “可能” 或 “将” 发生的陈述。

The forward-looking information contained herein, including the Company's continued evolution into a wellness company, the anticipated launch of a nutraceutical division in the fourth quarter of 2021 and certain actions the Company expects to take to operate more efficiently are only predictions and are made as of the date of this news release. Various assumptions were used in developing the forward-looking information throughout this news release which management believed to be reasonable at the time such statements were made, including expectations that the introduction of a new nutraceutical division, products and brands will generate additional revenue, management's perceptions of Lifeist's standing in the online marketplace for wellness, cannabis and related products and accessories, Lifeist's beliefs regarding the expected demand for wellness, cannabis and related products and accessories and the expected growth of that market, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: unforeseen developments that would delay the Company's ability to launch its nutraceutical division as anticipated an in a timely manner, risks relating to the Company's ability to develop and execute its business strategy and to implement its various cost cutting measures as anticipated and in a timely manner and the benefits realizable therefrom, risks specifically related to the Company's operations, and risks relating to the Company's ability to successfully operate everywhere in a virtual environment. Additional risk factors can also be found in the Company's current MD&A and annual information form, both of which have been filed under the Company's SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

此处包含的前瞻性信息,包括公司继续发展成为一家健康公司、预计在2021年第四季度成立营养保健部门以及公司为提高运营效率而预计采取的某些行动,只是预测,是截至本新闻稿发布之日做出的。在本新闻稿中,在制定前瞻性信息时使用了各种假设,管理层在发表此类声明时认为这些信息是合理的,包括对引入新的营养保健品部门、产品和品牌将产生额外收入的预期、管理层对Lifeist在健康、大麻及相关产品和配件的在线市场中的地位的看法、Lifeist对健康、大麻及相关产品和配件的预期需求的看法以及该市场的预期增长, 经营业绩, 经营事项, 历史趋势, 当前状况和预期的未来发展, 以及其他被认为适合这种情况的考虑因素.尽管根据管理层目前掌握的信息,我们认为这些假设是合理的,但无法保证这种预期会被证明是正确的。就其性质而言,前瞻性信息受固有的风险和不确定性的影响,这些风险和不确定性可能是普遍的或具体的,这可能导致预期、预测、预测、预测或结论不准确,假设可能不正确,目标、战略目标和优先事项无法实现。各种因素,包括已知和未知风险,其中许多是我们无法控制的,可能导致实际结果与本新闻稿中的前瞻性信息存在重大差异。这些因素包括但不限于:不可预见的事态发展将延迟公司按预期及时启动其营养品部门的能力,与公司制定和执行业务战略以及按预期及时实施各种削减成本措施的能力相关的风险以及由此带来的收益,与公司运营特别相关的风险,以及与公司在虚拟环境中成功运营的能力相关的风险环境。其他风险因素也可以在公司当前的MD&A和年度信息表中找到,这两份报告均已在公司的SEDAR简介下提交,网址为www.sedar.com。提醒读者不要过分依赖前瞻性信息。除非适用法律要求,否则公司没有义务更新或修改任何前瞻性信息,无论是由于新信息、未来事件还是其他原因。本新闻稿中包含的前瞻性陈述受到本警示声明的明确限制。

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任,也未以任何方式批准或不批准本新闻稿的内容。

Source: Lifeist Wellness Inc.

资料来源:Lifeist Wellness


译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发